IDSIQ

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark IDSIQ was filed as Word mark on 12/30/2020 at the World Intellectual Property Organization.

Trademark Details Last update: January 31, 2023

Trademark form Word mark
File reference 1584862
Register number 754999
Countries Australia Brazil Canada European Community United Kingdom Israel India Iceland Japan South Korea Mexico Norway New Zealand Singapore Turkey United States of America (USA) China Liechtenstein Russia Ukraine
Base trademark CH No. 754999, November 2, 2020
Application date December 30, 2020
Expiration date December 30, 2030

Trademark owner

Hegenheimermattweg 91
4123 Allschwil
CH

Trademark representatives

goods and services

09 Electronic publications (downloadable) in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
16 Printed matter (publications) in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
41 Multimedia publication of printed matter in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; multimedia publication of printed matter in the field of tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
42 Scientific research and development, namely pharmaceutical and medical testing services and development of pharmaceutical and medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; scientific research, namely analysis of objective data on patients by means of diagnostic tests in the context of drug administration, analysis of subjective data on patients by means of patient questioning, analysis of such data with the aim of optimizing drug treatments and drug administration

Trademark history

Date Document number Area Entry
September 21, 2022 2022/40 Gaz IS Rejection
September 19, 2022 2023/5 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
September 9, 2022 2022/37 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 20, 2022 2022/29 Gaz CA Rejection
July 4, 2022 2022/27 Gaz MX Rejection
April 20, 2022 2022/16 Gaz NO Rejection
April 1, 2022 2022/14 Gaz LI Rejection
March 17, 2022 2022/11 Gaz KR Rejection
February 10, 2022 2022/6 Gaz JP Rejection
February 8, 2022 2022/6 Gaz BR Rejection
February 3, 2022 2022/5 Gaz UA Rejection
December 15, 2021 2021/50 Gaz GB Rejection
December 5, 2021 2021/49 Gaz IL Rejection
November 6, 2021 2021/46 Gaz NO Rejection
November 2, 2021 2021/44 Gaz NZ Rejection
October 20, 2021 2021/42 Gaz TR Rejection
October 11, 2021 2021/41 Gaz IN Rejection
August 25, 2021 2021/35 Gaz EM Rejection
August 7, 2021 2021/33 Gaz SG Rejection
August 5, 2021 2021/31 Gaz CN Rejection
July 26, 2021 2021/30 Gaz US Rejection
June 29, 2021 2021/26 Gaz AU Rejection
June 14, 2021 2021/24 Gaz RU Rejection
December 30, 2020 2021/12 Gaz CH Registration

ID: 141584862